rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1983-2-14
|
pubmed:abstractText |
A 10-day course of amoxicillin (250 mg)-potassium clavulanate (125 mg) was administered three times daily to 116 female college students with urinary tract infections. All of the bacterial isolates from these patients were susceptible to amoxicillin-potassium clavulanate in vitro; only 81.0% were susceptible to amoxicillin alone. Evaluations at 1 week after completion of this course showed that clinical and bacteriological cures had been achieved in 96.9% of those who completed therapy. Cures were sustained in 85.6% of the patients examined at 4 weeks after the end of therapy. Therapeutic responses were comparable, irrespective of the results of antibody-coated bacteria tests. All strains of Enterobacteriaceae isolated from the rectal and urogenital sites at 1 week after therapy were susceptible to amoxicillin-potassium clavulanate. The proportion of fecal Escherichia coli resistant to amoxicillin alone increased from 13.3% before therapy to 35.6% at 1 week after therapy. Adverse drug reactions consisted of gastrointestinal symptoms (9.8%) and rashes (4.1%). Sixteen patients (14.2%) developed symptomatic candida vaginitis by 1 week after therapy.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-102630,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-1126306,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-13598782,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-13923136,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-14848119,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-310279,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-395156,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4248662,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4276178,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4518352,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4591064,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4920323,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4943333,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-5325707,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-6102627,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-6967713,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-6968541,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-6972732,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-6990474,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-7012997,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-7027925,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-7192302,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-932221
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0066-4804
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
672-7
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
|
pubmed:year |
1982
|
pubmed:articleTitle |
Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid.
|
pubmed:publicationType |
Journal Article
|